Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation Read more about Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study Read more about The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure Read more about TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction Read more about Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients Read more about The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease Read more about A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia Read more about A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia
Regulation of Endogenous Glucose Production by Central KATP Channels Read more about Regulation of Endogenous Glucose Production by Central KATP Channels
To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Read more about To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With